Lv4
460 积分 2024-11-23 加入
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
7天前
已完结
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B
7天前
已完结
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B
7天前
已完结
Viral Load–Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B
2个月前
已完结
Hypoxia and the endometrium: An indispensable role for HIF-1α as therapeutic strategies
3个月前
已完结
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
3个月前
已完结
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitia B
4个月前
已完结
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B
4个月前
已完结
Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy
4个月前
已完结
皖公网安备34019202002308
